Cynosure Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$808K Buy
3,180
+976
+44% +$227K 0.12% 60
2026
Q1
$539K Buy
+2,204
New +$513K 0.07% 78
2024
Q1
Sell
-1,580
Closed -$248K 332
2023
Q4
$248K Buy
+1,580
New +$242K 0.04% 138
2020
Q2
Sell
-3,313
Closed -$434K 38
2020
Q1
$434K Sell
3,313
-585
-15% -$83K 0.31% 36
2019
Q4
$569K Hold
3,898
0.3% 29
2019
Q3
$504K Sell
3,898
-1,379
-26% -$182K 0.27% 31
2019
Q2
$735K Buy
+5,277
New +$730K 0.34% 30

Other funds holding JNJ

Cynosure Group's JNJ Position: Q2 2026 in Review

Cynosure Group increased its Johnson & Johnson (JNJ) stake by 44% in Q2 2026, buying an estimated $227K and bringing the position to 3,180 shares worth $808K. The position accounts for 0.12% of the portfolio, ranked #60.

Cynosure Group first reported a position in JNJ in Q2 2019 and has held it in 7 quarters since. 4,680 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Cynosure Group held 3,180 shares of Johnson & Johnson worth $808K as of Q2 2026.
  • Cynosure Group bought 976 Johnson & Johnson shares in Q2 2026, an estimated $227K.
  • Johnson & Johnson made up 0.12% of Cynosure Group's portfolio in Q2 2026, its #60 holding.
  • Cynosure Group first reported a position in Johnson & Johnson in Q2 2019 and has held it in 7 quarters since.
  • 4,680 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Cynosure Group's 13F filing for Q2 2026, filed 5 Aug 2026.